Vanberra Signal

Nanite

Curated by Signal

Manufacturer of programmable polymer nanoparticles

Overview

Developing AI-driven non-viral gene delivery systems. It uses artificial intelligence to design and synthesize polymer nanoparticles for targeted and safe gene therapy. These nanoparticles offer advantages over traditional viral vectors and lipid nanoparticles, addressing a major hurdle in gene therapy. The company's platform combines high-throughput synthesis, biology, materials science, and artificial intelligence to create programmable and effective delivery vehicles for a wide range of genetic medicines. This approach aims to improve the efficacy and safety of gene therapies.

Key facts

Founded
2021

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of non-invasive home device for strengthening pelvic muscles control

    Life Sciences TechnologyMonroe, United States
  • Provider of AI-based personal genome interpretation

    Life Sciences TechnologyNew York City, United States

About Nanite

What does Nanite do?

Developing AI-driven non-viral gene delivery systems.

Where is Nanite headquartered?

Nanite is headquartered in Boston, United States.

When was Nanite founded?

Nanite was founded in 2021.

Which sector is Nanite in?

Nanite operates in Life Sciences Technology.

Who are Nanite's competitors?

Companies similar to Nanite include Elidah, AI Health, and Precision Medicine Calculator.